跳至主要内容
临床试验/NCT05259579
NCT05259579Unknown不适用

Anti-reflux Mucosal Ablation (ARMA) for the Treatment of Postoperative Gastroesophageal Reflux After Sleeve Gastrectomy - A Pilot Study

Chinese University of Hong Kong1 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2022年2月1日最近更新:
适应症

试验速览

阶段
不适用
入组人数
15
试验地点
1
主要终点
Change in GERD symptoms

研究概览

简要总结

This study is a pilot trial designed to evaluate the safety and efficacy of endoscopic anti-reflux ablation in postoperative gastroesophageal reflux after sleeve gastrectomy

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with reflux symptoms after sleeve gastrectomy and are dependent on or refractory to PPI treatment
  • Pathological esophageal acid exposure, defined by DeMeester score >14.7 or acid exposure time (AET) >4.2% on pH study

排除标准

  • Primary esophageal motility disorders
  • Sliding hiatal hernia >3cm
  • Narrow gastric sleeve that precludes retroflexion of scope
  • Gastric sleeve stricture
  • Malignancy
  • Pregnancy
  • Patients not fit for general anesthesia
  • Other cases deemed by the examining physician as unsuitable for safe treatment
  • Refusal to participate

结局指标

主要结局

Change in GERD symptoms

时间窗: 3 and 6months

Gastroesophageal Reflux Disease-Health-Related Quality of Life (GERD-HRQL) questionnaire score \[0-75, higher scores mean worse outcome\]

次要结局

  • Technical success rate(1 day)
  • Changes in cardia morphology(3 months)
  • Dysphagia symptoms(3 and 6 months)
  • Adverse events rate relating to endoscopic intervention(7 days, 1, 3 and 6 months)
  • Change in DeMeester score and AET(3 months)
  • PPI use(3 and 6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Stephen K.K. Ng

Principal Investigator

Chinese University of Hong Kong

研究点 (1)

Loading locations...

相似试验